CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE

CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE was reported 658 times

CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 2 0.0870
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 49 0.0734
2 SWOLLEN JOINT COUNT 15 0.0600
3 LUPUS VULGARIS 65 0.0516
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 100 0.0499
5 SWOLLEN JOINT COUNT DECREASED 1 0.0476
6 SWOLLEN JOINT COUNT INCREASED 123 0.0385
7 RHEUMATOID FACTOR POSITIVE 205 0.0355
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 70 0.0338
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 242 0.0337
10 DISLOCATION OF VERTEBRA 74 0.0324
11 SERONEGATIVE ARTHRITIS 36 0.0314
12 RHEUMATIC FEVER 140 0.0314
13 C-REACTIVE PROTEIN 28 0.0302
14 DUODENAL ULCER PERFORATION 216 0.0290
15 PEMPHIGUS 353 0.0282
16 RETINITIS 44 0.0254
17 FACET JOINT SYNDROME 80 0.0245
18 X-RAY ABNORMAL 43 0.0240
19 TENDER JOINT COUNT 2 0.0238
20 HAND DEFORMITY 311 0.0237
21 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 13 0.0232
22 HELICOBACTER INFECTION 197 0.0191
23 PERICARDITIS 295 0.0175
24 GRIP STRENGTH 4 0.0175
25 HYPOCHOLESTEROLAEMIA 6 0.0170
26 PERIPHERAL VENOUS DISEASE 69 0.0169
27 DRUG TOLERANCE DECREASED 42 0.0149
28 SYNOVITIS 262 0.0145
29 BONE EROSION 51 0.0144
30 ACQUIRED PORPHYRIA 1 0.0141
31 GLOSSODYNIA 315 0.0141
32 MUSCLE INJURY 110 0.0133
33 FOLLICULITIS 125 0.0119
34 BREAST CANCER STAGE III 76 0.0117
35 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 75 0.0115
36 WOUND 301 0.0108
37 C-REACTIVE PROTEIN ABNORMAL 64 0.0100
38 AUTOIMMUNE DISORDER 95 0.0097
39 LIVE BIRTH 81 0.0097
40 SYSTEMIC LUPUS ERYTHEMATOSUS 342 0.0096
41 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 1 0.0095
42 HYPERCHOLESTEROLAEMIA 77 0.0080
43 EXOSTOSIS 71 0.0078
44 WOUND INFECTION 84 0.0077
45 CONTRAINDICATED PRODUCT ADMINISTERED 226 0.0075
46 GRIP STRENGTH DECREASED 65 0.0074
47 SPONDYLITIS 26 0.0071
48 PORPHYRIA ACUTE 9 0.0063
49 LIP DRY 57 0.0063
50 WALKING AID USER 41 0.0062
51 JOINT RANGE OF MOTION DECREASED 81 0.0060
52 INFUSION SITE REACTION 18 0.0060
53 BURSITIS 72 0.0059
54 LIVER INJURY 145 0.0059
55 BLEPHAROSPASM 37 0.0059
56 DEATH NEONATAL 8 0.0057
57 PRESCRIBED OVERDOSE 109 0.0056
58 FIBROMYALGIA 132 0.0054
59 JOINT DESTRUCTION 8 0.0051
60 ARTHROPATHY 281 0.0051
61 TYPE 2 DIABETES MELLITUS 166 0.0049
62 RED BLOOD CELL SEDIMENTATION RATE INCREASED 53 0.0048
63 HIP ARTHROPLASTY 72 0.0047
64 LOWER LIMB FRACTURE 90 0.0047
65 IRRITABLE BOWEL SYNDROME 100 0.0047
66 PEAK EXPIRATORY FLOW RATE DECREASED 2 0.0045
67 LUPUS-LIKE SYNDROME 41 0.0045
68 DISCOMFORT 269 0.0044
69 SCIATICA 69 0.0043
70 OVERLAP SYNDROME 3 0.0043
71 BREAST CANCER STAGE II 35 0.0042
72 PRESCRIBED UNDERDOSE 83 0.0042
73 FOOT DEFORMITY 46 0.0041
74 INFUSION RELATED REACTION 267 0.0040
75 PULMONARY FIBROSIS 76 0.0040
76 DRUG TOLERANCE 20 0.0039
77 EYE INJURY 12 0.0039
78 PSORIATIC ARTHROPATHY 149 0.0037
79 THERAPEUTIC PRODUCT EFFECT DECREASED 164 0.0037
80 MATERNAL EXPOSURE DURING PREGNANCY 325 0.0036
81 JOINT DISLOCATION 38 0.0036
82 ONYCHOMADESIS 15 0.0036
83 ULCER HAEMORRHAGE 24 0.0035
84 HEPATIC ENZYME INCREASED 239 0.0035
85 SPINAL FUSION SURGERY 14 0.0034
86 KNEE ARTHROPLASTY 71 0.0034
87 OBESITY 53 0.0033
88 IMPAIRED HEALING 108 0.0033
89 BLOOD CHOLESTEROL INCREASED 150 0.0032
90 SWELLING 296 0.0032
91 GAIT INABILITY 105 0.0031
92 MITE ALLERGY 2 0.0031
93 RHEUMATOID ARTHRITIS 347 0.0031
94 PUSTULAR PSORIASIS 10 0.0029
95 PSEUDOSTROKE 1 0.0029
96 BRONCHIAL OBSTRUCTION 4 0.0028
97 DRUG INTOLERANCE 274 0.0028
98 STAB WOUND 1 0.0028
99 BLISTER 154 0.0027
100 TREATMENT FAILURE 223 0.0027
101 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 45 0.0026
102 HEPATIC CIRRHOSIS 49 0.0026
103 SKIN TURGOR DECREASED 1 0.0026
104 NECK DEFORMITY 1 0.0023
105 JOINT STIFFNESS 57 0.0022
106 JOINT SWELLING 260 0.0022
107 OEDEMA 116 0.0021
108 MATERNAL EXPOSURE TIMING UNSPECIFIED 8 0.0021
109 ABDOMINAL DISCOMFORT 353 0.0021
110 NIGHT SWEATS 67 0.0021
111 OSTEOARTHRITIS 87 0.0021
112 INJURY 142 0.0020
113 RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
114 EAR PAIN 39 0.0020
115 DELIRIUM 69 0.0020
116 LOWER RESPIRATORY TRACT INFECTION 89 0.0020
117 EPILEPSY 58 0.0019
118 ROAD TRAFFIC ACCIDENT 79 0.0019
119 EAR INFECTION 50 0.0019
120 ALLERGY TO ANIMAL 2 0.0019
121 WHEEZING 111 0.0019
122 MUSCULOSKELETAL STIFFNESS 163 0.0019
123 STOMATITIS 111 0.0018
124 DISABILITY 36 0.0018
125 MOBILITY DECREASED 129 0.0018
126 THERAPY NON-RESPONDER 79 0.0018
127 VACCINATION SITE PAIN 1 0.0017
128 C-REACTIVE PROTEIN INCREASED 63 0.0017
129 NAIL DISORDER 15 0.0017
130 ALOPECIA 335 0.0017
131 INTENTIONAL PRODUCT USE ISSUE 138 0.0016
132 ANAL INFLAMMATION 1 0.0016
133 MUCOSAL DISCOLOURATION 1 0.0016
134 LIVER FUNCTION TEST INCREASED 33 0.0015
135 POLYARTHRITIS 8 0.0015
136 SARS-COV-2 TEST NEGATIVE 1 0.0015
137 TASTE DISORDER 30 0.0015
138 NORMAL NEWBORN 8 0.0015
139 RASH VESICULAR 7 0.0014
140 OPHTHALMIC MIGRAINE 1 0.0014
141 CONGENITAL ANOMALY 11 0.0014
142 HYPERSENSITIVITY 261 0.0014
143 BACK INJURY 15 0.0014
144 PREGNANCY 27 0.0013
145 GINGIVAL ABSCESS 1 0.0013
146 MUSCULOSKELETAL PAIN 68 0.0013
147 ORAL MUCOSAL ERYTHEMA 2 0.0013
148 EXPOSURE DURING PREGNANCY 80 0.0013
149 LUNG DISORDER 63 0.0013
150 INFLAMMATION 65 0.0013
151 EXPOSURE VIA BREAST MILK 5 0.0013
152 GENERAL PHYSICAL HEALTH DETERIORATION 144 0.0012
153 BRONCHOPULMONARY DYSPLASIA 1 0.0012
154 DRUG-INDUCED LIVER INJURY 39 0.0012
155 LIVER DISORDER 55 0.0012
156 MUSCLE SPASTICITY 15 0.0012
157 INCREASED BRONCHIAL SECRETION 3 0.0012
158 SLEEP DISORDER 81 0.0011
159 VERTIGO POSITIONAL 2 0.0011
160 MYOSITIS 10 0.0011
161 RESPIRATORY DISORDER 33 0.0011
162 ADVERSE EVENT 99 0.0011
163 THERAPEUTIC RESPONSE INCREASED 1 0.0011
164 GASTROINTESTINAL DISORDER 95 0.0011
165 DRY MOUTH 86 0.0011
166 PRODUCT USE ISSUE 196 0.0010
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 50 0.0010
168 ILL-DEFINED DISORDER 63 0.0010
169 HYPERTRANSAMINASAEMIA 7 0.0010
170 DYSPEPSIA 99 0.0010
171 OSTEOPOROSIS 41 0.0010
172 UPPER RESPIRATORY TRACT INFECTION 46 0.0010
173 SINUSITIS 102 0.0010
174 HYPOAESTHESIA 147 0.0010
175 AMNESIA 63 0.0010
176 ADVERSE DRUG REACTION 86 0.0010
177 MIGRAINE 91 0.0010
178 JAW FRACTURE 2 0.0009
179 ASTHMA 101 0.0009
180 CONTUSION 86 0.0009
181 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
182 PRURITUS ALLERGIC 1 0.0009
183 INFECTION 122 0.0008
184 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14 0.0008
185 GENERAL SYMPTOM 6 0.0008
186 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
187 LACTOSE INTOLERANCE 2 0.0008
188 URTICARIA 128 0.0008
189 HYPERSENSITIVITY VASCULITIS 2 0.0008
190 IMMUNODEFICIENCY 11 0.0007
191 PERIPHERAL SWELLING 112 0.0007
192 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
193 ONYCHOMYCOSIS 3 0.0007
194 CONJUNCTIVITIS ALLERGIC 1 0.0007
195 RASH 294 0.0007
196 SUSPECTED OFF LABEL USE 3 0.0007
197 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47 0.0007
198 ADRENAL INSUFFICIENCY 8 0.0007
199 NASOPHARYNGITIS 121 0.0007
200 PNEUMONIA PSEUDOMONAL 1 0.0007
201 MUSCULAR WEAKNESS 74 0.0007
202 HYPERTENSION 136 0.0006
203 CONDITION AGGRAVATED 195 0.0006
204 OEDEMA PERIPHERAL 77 0.0006
205 LIMB DEFORMITY 1 0.0006
206 CONFUSIONAL STATE 100 0.0006
207 COELIAC DISEASE 6 0.0006
208 BRONCHITIS 44 0.0006
209 PRODUCT USE IN UNAPPROVED INDICATION 147 0.0006
210 PAIN 348 0.0006
211 JOINT ARTHROPLASTY 1 0.0006
212 DECREASED APPETITE 126 0.0005
213 MEMORY IMPAIRMENT 74 0.0005
214 CHEST PAIN 99 0.0005
215 ABDOMINAL PAIN UPPER 110 0.0005
216 ARTHRITIS 42 0.0005
217 HYPERVENTILATION 3 0.0005
218 COLITIS ULCERATIVE 23 0.0005
219 GAIT DISTURBANCE 98 0.0005
220 WEIGHT INCREASED 112 0.0005
221 THERAPEUTIC RESPONSE DECREASED 30 0.0005
222 MEDICATION ERROR 27 0.0005
223 VISUAL IMPAIRMENT 58 0.0005
224 DEREALISATION 1 0.0005
225 MIDDLE EAR EFFUSION 1 0.0005
226 PARAESTHESIA 71 0.0005
227 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
228 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1 0.0004
229 BACK DISORDER 7 0.0004
230 ARTHRALGIA 172 0.0004
231 FATIGUE 322 0.0004
232 FINGER DEFORMITY 2 0.0004
233 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
234 MULTIPLE ALLERGIES 3 0.0004
235 RHINITIS 3 0.0004
236 TREATMENT NONCOMPLIANCE 20 0.0004
237 TACHYCARDIA 32 0.0004
238 PERIORBITAL SWELLING 2 0.0004
239 NECK MASS 1 0.0004
240 MUSCLE SPASMS 63 0.0003
241 PRODUCT LABEL CONFUSION 2 0.0003
242 PAIN IN EXTREMITY 99 0.0003
243 SPINAL DISORDER 3 0.0003
244 PSORIASIS 41 0.0003
245 INFLAMMATORY BOWEL DISEASE 3 0.0003
246 ANXIETY 86 0.0003
247 SKIN INJURY 1 0.0003
248 UNDERDOSE 22 0.0003
249 TERMINAL STATE 2 0.0003
250 FREQUENT BOWEL MOVEMENTS 8 0.0003
251 DEPRESSION 67 0.0003
252 ABDOMINAL PAIN 66 0.0003
253 VOMITING 133 0.0003
254 HAND FRACTURE 2 0.0003
255 DRUG INEFFECTIVE 363 0.0003
256 PNEUMONIA 89 0.0003
257 PYREXIA 93 0.0003
258 BONE DENSITY ABNORMAL 1 0.0003
259 PARANASAL SINUS DISCOMFORT 1 0.0003
260 DIZZINESS 131 0.0003
261 WEIGHT DECREASED 71 0.0003
262 SINUS DISORDER 5 0.0003
263 INSOMNIA 67 0.0003
264 OFF LABEL USE 218 0.0002
265 DYSPNOEA 139 0.0002
266 HEADACHE 150 0.0002
267 NECK PAIN 13 0.0002
268 MALAISE 102 0.0002
269 PRURITUS 88 0.0002
270 EOSINOPHILIA 4 0.0002
271 ASTHENIA 85 0.0002
272 PURPURA 2 0.0002
273 URINARY TRACT DISORDER 1 0.0002
274 FLUID RETENTION 11 0.0002
275 PRODUCT DISTRIBUTION ISSUE 2 0.0002
276 ARTHRITIS INFECTIVE 1 0.0002
277 SKIN TIGHTNESS 1 0.0002
278 FEELING HOT 13 0.0002
279 SKIN ABRASION 1 0.0002
280 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
281 NASAL POLYPS 1 0.0002
282 PANCREATIC DISORDER 1 0.0002
283 DIARRHOEA 129 0.0002
284 PRODUCT QUALITY ISSUE 27 0.0002
285 PHLEBITIS 1 0.0002
286 HYPOKALAEMIA 9 0.0002
287 VARICOSE VEIN 1 0.0002
288 RESPIRATORY TRACT INFECTION 5 0.0002
289 WEIGHT FLUCTUATION 2 0.0002
290 SENSITIVITY TO WEATHER CHANGE 1 0.0002
291 SCRATCH 2 0.0002
292 PANCREATITIS 10 0.0002
293 ASPIRATION 2 0.0002
294 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
295 INTRACRANIAL PRESSURE INCREASED 1 0.0002
296 HEART RATE ABNORMAL 1 0.0002
297 DECREASED INTEREST 1 0.0002
298 LABORATORY TEST ABNORMAL 5 0.0002
299 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
300 SINUS HEADACHE 1 0.0002
301 SYMPTOM RECURRENCE 1 0.0002
302 NAUSEA 131 0.0002
303 RECTAL HAEMORRHAGE 7 0.0002
304 CONJUNCTIVITIS 3 0.0002
305 MIDDLE INSOMNIA 3 0.0002
306 PROCTALGIA 1 0.0002
307 APPETITE DISORDER 1 0.0002
308 HOSPITALISATION 23 0.0001
309 BODY TEMPERATURE INCREASED 3 0.0001
310 RESPIRATION ABNORMAL 1 0.0001
311 LEUKOPENIA 7 0.0001
312 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
313 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
314 SNEEZING 3 0.0001
315 NASAL DISCOMFORT 1 0.0001
316 RESPIRATORY TRACT CONGESTION 2 0.0001
317 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
318 HYPERAESTHESIA 1 0.0001
319 SKIN PLAQUE 1 0.0001
320 PSEUDOMONAS INFECTION 1 0.0001
321 OROPHARYNGEAL DISCOMFORT 1 0.0001
322 BREAST CANCER STAGE I 1 0.0001
323 PRODUCTIVE COUGH 5 0.0001
324 HAEMORRHOIDS 2 0.0001
325 NASAL CONGESTION 6 0.0001
326 THERAPY CHANGE 1 0.0001
327 KNEE OPERATION 1 0.0001
328 ILLNESS 10 0.0001
329 TENDERNESS 1 0.0001
330 PHARYNGITIS STREPTOCOCCAL 1 0.0001
331 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
332 OCULAR DISCOMFORT 1 0.0001
333 LOSS OF CONSCIOUSNESS 11 0.0001
334 ACCIDENT 1 0.0001
335 SPINAL OPERATION 1 0.0001
336 PHARYNGITIS 1 0.0001
337 CYST 1 0.0001
338 INTENTIONAL PRODUCT MISUSE 7 0.0001
339 DIABETES MELLITUS 6 0.0001
340 INTRAOCULAR PRESSURE INCREASED 1 0.0001
341 HIATUS HERNIA 1 0.0001
342 ADVERSE REACTION 1 0.0001
343 THROAT TIGHTNESS 2 0.0001
344 PROCEDURAL PAIN 2 0.0001
345 MASS 1 0.0001
346 SKIN REACTION 1 0.0001
347 ANOSMIA 1 0.0001
348 NEEDLE ISSUE 2 0.0001
349 BONE LOSS 1 0.0001
350 INSURANCE ISSUE 1 0.0001
351 THERAPY PARTIAL RESPONDER 1 0.0001
352 BONE DENSITY DECREASED 2 0.0001
353 BRAIN FOG 1 0.0001
354 DISEASE RECURRENCE 3 0.0001
355 ULCER 1 0.0001
356 MUSCLE TIGHTNESS 1 0.0001
357 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
358 INJECTION SITE REACTION 4 0.0001
359 ORTHOSTATIC HYPOTENSION 1 0.0001
360 SYRINGE ISSUE 1 0.0001
361 METASTASES TO LIVER 1 0.0001
362 HEAD DISCOMFORT 1 0.0001
363 RASH PRURITIC 3 0.0001
364 ACCIDENTAL OVERDOSE 2 0.0001
365 THINKING ABNORMAL 1 0.0001
366 FEELING JITTERY 1 0.0001
367 INCREASED APPETITE 1 0.0001
368 ACUTE RESPIRATORY FAILURE 1 0.0001
369 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
370 PALPITATIONS 6 0.0001
371 KIDNEY INFECTION 1 0.0001
372 INJECTION SITE BRUISING 4 0.0001
373 VERTIGO 3 0.0000
374 CHEST DISCOMFORT 5 0.0000
375 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
376 PRODUCT PRESCRIBING ISSUE 1 0.0000
377 PRODUCT AVAILABILITY ISSUE 1 0.0000
378 PERICARDIAL EFFUSION 1 0.0000
379 BLOOD PRESSURE FLUCTUATION 1 0.0000
380 AGEUSIA 1 0.0000
381 HYPOPHAGIA 1 0.0000
382 HEPATITIS 1 0.0000
383 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
384 LIMB INJURY 1 0.0000
385 PALLOR 1 0.0000
386 PNEUMONITIS 1 0.0000
387 FEELING COLD 1 0.0000
388 OXYGEN SATURATION DECREASED 2 0.0000
389 EYE PAIN 2 0.0000
390 ANGINA PECTORIS 1 0.0000
391 HYPERSOMNIA 1 0.0000
392 HERPES ZOSTER 2 0.0000
393 PANCREATIC CARCINOMA 1 0.0000
394 CATARACT 2 0.0000
395 NO ADVERSE EVENT 6 0.0000
396 APHASIA 1 0.0000
397 EMOTIONAL DISORDER 1 0.0000
398 NERVOUS SYSTEM DISORDER 1 0.0000
399 MOOD SWINGS 1 0.0000
400 MOVEMENT DISORDER 1 0.0000
401 EYE DISORDER 1 0.0000
402 STAPHYLOCOCCAL INFECTION 1 0.0000
403 HEART RATE INCREASED 3 0.0000
404 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
405 FUNGAL INFECTION 1 0.0000
406 ANGER 1 0.0000
407 COUGH 8 0.0000
408 HYPOXIA 1 0.0000
409 DEATH 24 0.0000
410 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
411 PANIC ATTACK 1 0.0000
412 EYE SWELLING 1 0.0000
413 THROMBOCYTOPENIA 3 0.0000
414 DYSARTHRIA 1 0.0000
415 COLITIS 1 0.0000
416 DISORIENTATION 1 0.0000
417 THROMBOSIS 2 0.0000
418 OVERDOSE 5 0.0000
419 VAGINAL HAEMORRHAGE 1 0.0000
420 THROAT IRRITATION 1 0.0000
421 BACK PAIN 5 0.0000
422 OCULAR HYPERAEMIA 1 0.0000
423 NEUROPATHY PERIPHERAL 2 0.0000
424 FEELING ABNORMAL 5 0.0000
425 PRODUCT DOSE OMISSION ISSUE 6 0.0000
426 AGGRESSION 1 0.0000
427 HYPOTENSION 4 0.0000
428 FLUSHING 2 0.0000
429 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
430 NERVOUSNESS 1 0.0000
431 ECZEMA 1 0.0000
432 DEPRESSED MOOD 1 0.0000
433 DRUG EFFECT DECREASED 1 0.0000
434 ANAPHYLACTIC REACTION 1 0.0000
435 MYALGIA 3 0.0000
436 URINARY TRACT INFECTION 3 0.0000
437 PRODUCT SUBSTITUTION ISSUE 1 0.0000
438 SURGERY 1 0.0000
439 RHINORRHOEA 1 0.0000
440 DEEP VEIN THROMBOSIS 1 0.0000
441 SWELLING FACE 1 0.0000
442 PRODUCT DOSE OMISSION 1 0.0000
443 FEBRILE NEUTROPENIA 1 0.0000
444 SOMNOLENCE 3 0.0000
445 VISION BLURRED 2 0.0000
446 AGITATION 1 0.0000
447 ACNE 1 0.0000
448 DRUG INTERACTION 2 0.0000
449 CARDIAC FAILURE CONGESTIVE 1 0.0000
450 TREMOR 2 0.0000
451 BALANCE DISORDER 1 0.0000
452 DEVICE ISSUE 1 0.0000
453 SUICIDAL IDEATION 1 0.0000
454 OROPHARYNGEAL PAIN 1 0.0000
455 BREAST CANCER 1 0.0000
456 CARDIAC DISORDER 1 0.0000
457 ATRIAL FIBRILLATION 1 0.0000
458 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
459 ERYTHEMA 2 0.0000
460 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
461 ABDOMINAL DISTENSION 1 0.0000
462 HAEMORRHAGE 1 0.0000
463 PLATELET COUNT DECREASED 1 0.0000
464 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
465 CONSTIPATION 2 0.0000
466 INFLUENZA 1 0.0000
467 INCORRECT DOSE ADMINISTERED 2 0.0000
468 CHILLS 1 0.0000
469 DEHYDRATION 1 0.0000
470 DRY SKIN 1 0.0000
471 NEUTROPENIA 1 0.0000
472 BLOOD PRESSURE INCREASED 1 0.0000
473 FALL 2 0.0000
474 MYOCARDIAL INFARCTION 1 0.0000
475 COVID-19 1 0.0000
476 ANAEMIA 1 0.0000
477 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
478 INJECTION SITE PAIN 1 0.0000